These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
578 related items for PubMed ID: 22200518
21. Screening for anxiety disorders in patients with coronary artery disease. Bunevicius A, Staniute M, Brozaitiene J, Pop VJ, Neverauskas J, Bunevicius R. Health Qual Life Outcomes; 2013 Mar 11; 11():37. PubMed ID: 23497087 [Abstract] [Full Text] [Related]
26. Comparison of the hospital anxiety and depression scale and the center for epidemiological studies depression scale for detecting depression in women with breast or gynecologic cancer. Stafford L, Judd F, Gibson P, Komiti A, Quinn M, Mann GB. Gen Hosp Psychiatry; 2014 Mar 11; 36(1):74-80. PubMed ID: 24200105 [Abstract] [Full Text] [Related]
28. Depression in chronic pain patients: prevalence and measurement. Poole H, White S, Blake C, Murphy P, Bramwell R. Pain Pract; 2009 Mar 11; 9(3):173-80. PubMed ID: 19298363 [Abstract] [Full Text] [Related]
29. Sensitivity and specificity of the Beck Depression Inventory in cardiologic inpatients: how useful is the conventional cut-off score? Forkmann T, Vehren T, Boecker M, Norra C, Wirtz M, Gauggel S. J Psychosom Res; 2009 Oct 11; 67(4):347-52. PubMed ID: 19773028 [Abstract] [Full Text] [Related]
30. Cognitive and anxiety symptoms in screening for clinical depression in diabetes: a systematic examination of diagnostic performances of the HADS and BDI-SF. Sultan S, Luminet O, Hartemann A. J Affect Disord; 2010 Jun 11; 123(1-3):332-6. PubMed ID: 19861228 [Abstract] [Full Text] [Related]
32. Use of the hospital anxiety and depression scale as a screening tool for patients with headache. Juang KD, Wang SJ, Lin CH, Fuh JL. Zhonghua Yi Xue Za Zhi (Taipei); 1999 Nov 11; 62(11):749-55. PubMed ID: 10575802 [Abstract] [Full Text] [Related]
33. Screening for mental disorders in leprosy patients: comparing the internal consistency and screening properties of HADS and GHQ-12. Senturk V, Stewart R, Sagduyu A. Lepr Rev; 2007 Sep 11; 78(3):231-42. PubMed ID: 18035774 [Abstract] [Full Text] [Related]
34. Validation of diagnostic tests for depressive disorder in drug-resistant mesial temporal lobe epilepsy. de Lemos Zingano B, Guarnieri R, Diaz AP, Schwarzbold ML, Bicalho MA, Claudino LS, Markowitsch HJ, Wolf P, Lin K, Walz R. Epilepsy Behav; 2015 Sep 11; 50():61-6. PubMed ID: 26119622 [Abstract] [Full Text] [Related]
35. Evaluation of screening instruments for depression and anxiety in breast cancer survivors. Alexander S, Palmer C, Stone PC. Breast Cancer Res Treat; 2010 Jul 11; 122(2):573-8. PubMed ID: 19960243 [Abstract] [Full Text] [Related]
36. Validity and reliability of the Hospital Anxiety and Depression Scale in a hypertrophic cardiomyopathy clinic: the HADS in a cardiomyopathy population. Poole NA, Morgan JF. Gen Hosp Psychiatry; 2006 Jul 11; 28(1):55-8. PubMed ID: 16377366 [Abstract] [Full Text] [Related]
37. [A comparative validation of the scale CES-D, BDI, and HADS(d) in diagnosis of depressive disorders in general practice]. Andriushchenko AV, Drobizhev MIu, Dobrovol'skiĭ AV. Zh Nevrol Psikhiatr Im S S Korsakova; 2003 Jul 11; 103(5):11-8. PubMed ID: 12789819 [Abstract] [Full Text] [Related]
40. Validation of two depression screening instruments in a sleep disorders clinic. Law M, Naughton MT, Dhar A, Barton D, Dabscheck E. J Clin Sleep Med; 2014 Jun 15; 10(6):683-8. PubMed ID: 24932150 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]